Navigation Links
Groundbreaking Study Gives Hope For Patients With Kidney Cancer

German researchers have developed what appears to be an effective vaccine against recurrent kidney cancers.// Kidney cancer accounts for about 3 percent of all cancers and causes about 12,000 deaths in the United States every year. The disease most often strikes those in their 50s and 60s. Standard treatment involves removal of all or part of the kidney. Unlike some other cancers, however, kidney cancer does not respond well to subsequent treatment with chemotherapy or radiotherapy. About half of all patients diagnosed with the disease will have a recurrence after the initial surgery.

Scientists tested vaccines custom made using the individual tumors from kidney cancer patients. The study involved 558 patients scheduled for surgery for kidney cancer. About half the group received six vaccine injections at four-week intervals following surgery. The other half received no additional treatment .The patients were then followed for five years. Among the 379 patients for whom follow up data were available, 77 percent of those who received the vaccinations were still alive without a recurrence of the disease. This compares to 68 percent of those who did not receive the injections.

Researchers conclude saying that,such a milestone could serve as a concrete step towards making adjuvant treatment of renal cancer a routine and effective intervention.
'"/>




Page: 1

Related medicine news :

1. Groundbreaking Asthma Intervention Lessons Help Inner-City Children
2. Tomato Sauce reduces Cancer Risk- Study
3. Study on obesity and heart failure
4. National Lung Study in the process
5. Study casts doubt on keyboard ills
6. Study reveals how stress can make you sick
7. Study reveals how stress can make you sick
8. Study supports vegetable diet
9. Study to look at early surgery to treat epilepsy
10. Its Never Too Late to Stop Smoking,Study Finds
11. New Technique to Study Infants Brain.
Post Your Comments:
(Date:7/8/2008)...WASHINGTON, July 8, 2008) The American Society of...al recipients of its Alternative Training Pathway ...ctors to encourage the development and implementat... , Thomas Abshire, MD, of Emory University, Don..., and David Sternberg, MD, PhD, of Mount Sinai Sch...
(Date:7/8/2008)...is new executive team will give the men we serve a...aid Carl J. Bentley, President, M.I. Board of ...y 8 /PRNewswire/ -- The Mariners Inn shelter and t...the appointment of Jim Hartz as,chief executive of...., "Both Jim and David are outstanding leaders in...
(Date:7/8/2008)...ecently identified genetic markers, called single ...ed with a small but statistically significant incr... substantially improve the accuracy of existing mo...idual,s risk, according to a study in the July 8 o... Institute . , Risk prediction models provide es...
(Date:7/8/2008)...Will Not Reduce Competition and Will Help to Lower...engthen the Pennsylvania Economy, PITTSBURGH, Jul...rk and,Independence Blue Cross (IBC) testified her...ment public hearing about the combination of,the t...omers, health care,providers, and the communities ...
Breaking Medicine News(10 mins):Health News:Mariners Inn Announces New Executive Leadership 2Health News:Single-nucleotide polymorphisms do not substantially improve risk prediction for breast cancer 2Health News:Highmark and Independence Blue Cross CEOs Say Combination of Highmark and Independence Blue Cross will Provide $1 Billion in New Resources Over Six Years 2
...ts of fake medicines, most of them from India, wer...// , according to officials here. The fake medici...t cancer and high cholesterol and condoms. A sampl...what was being passed off as a cardiovascular drug...
...e developed a new method that advocates the use of...s// . D. Karunagaran, a professor at the departme...hnology (IIT) in Madras, and Suby Oommen, a PhD st...iotechnology in Kerala, have been working on garli...
...ed that there are crucial differences in brain che...cts stress and emotions.// The study adds further...c alterations within the brain -- specifically in ...a central part of the brain's natural pain and str...
...ity of Michigan Medical School have uncovered the ...renal failure //in children, which is because of m...or PLCE1. Discovering the mutant gene is crucial ...e development of podocytes – that are unique cells...
Other Medicine News:Health News:Garlic compound may help treat cancer 2Health News:Women in the throes of depression portray differences in brain chemistry 2Health News:Women in the throes of depression portray differences in brain chemistry 3Health News:Chronic Kidney Disease Related To Mutant Gene 2Health News:Chronic Kidney Disease Related To Mutant Gene 3Health News:Chronic Kidney Disease Related To Mutant Gene 4
(Date:7/8/2008)... NEW YORK, July 8 /- McGraw-Hill...ation resources for the scientific and medical,com... new drug,effectiveness reference to its comprehen...rmacy (http://www.accesspharmacy.com ). Through a...ributed databases generated from clinical,studies,...
(Date:7/8/2008)... - Focalin XR demonstrated better symptom contr...post-dose in primary and secondary endpoints,- Onl...30 minutes post-dose, - Additional analysis sugges... Concerta over 12 hours - Sym...(ADHD) can,significantly impact a child,s ability ...
(Date:7/7/2008)... - Dimebon Significantly Improves Cognition a...ton,s Disease Patients - - Findings Warrant Fur...- Conference Call Scheduled for Today at 5:00 p.m....ll/ -- Medivation, Inc.,(Nasdaq: MDVN ) today ann...,that its investigational drug Dimebon(TM) signifi...
(Date:7/7/2008)... NEW YORK, July 7 /- P...s announced that its subsidiary, PulmoScience,Inc.... DFH-12 product,candidate for the PulmoBind techno...f the lungs., Molecular Imaging uses a molecule d...he body. In the case of PulmoBind, the chosen mole...
Breaking Medicine Technology:McGraw-Hill Professional Launches Drug Effectiveness Resource on AccessPharmacy 2Head-to-Head Study Demonstrates Focalin(R) XR Offers Faster and Better Symptom Control than Concerta(R)1 in Early Part of ADHD Patients' Day 2Head-to-Head Study Demonstrates Focalin(R) XR Offers Faster and Better Symptom Control than Concerta(R)1 in Early Part of ADHD Patients' Day 3Head-to-Head Study Demonstrates Focalin(R) XR Offers Faster and Better Symptom Control than Concerta(R)1 in Early Part of ADHD Patients' Day 4Head-to-Head Study Demonstrates Focalin(R) XR Offers Faster and Better Symptom Control than Concerta(R)1 in Early Part of ADHD Patients' Day 5Head-to-Head Study Demonstrates Focalin(R) XR Offers Faster and Better Symptom Control than Concerta(R)1 in Early Part of ADHD Patients' Day 6Head-to-Head Study Demonstrates Focalin(R) XR Offers Faster and Better Symptom Control than Concerta(R)1 in Early Part of ADHD Patients' Day 7Head-to-Head Study Demonstrates Focalin(R) XR Offers Faster and Better Symptom Control than Concerta(R)1 in Early Part of ADHD Patients' Day 8Medivation Announces Positive Top-Line Results From Phase 2 Dimebon Study in Huntington's Disease 2Medivation Announces Positive Top-Line Results From Phase 2 Dimebon Study in Huntington's Disease 3Medivation Announces Positive Top-Line Results From Phase 2 Dimebon Study in Huntington's Disease 4Medivation Announces Positive Top-Line Results From Phase 2 Dimebon Study in Huntington's Disease 5Pulmo BioTech Inc. Completes Bio-Distribution Studies 2Pulmo BioTech Inc. Completes Bio-Distribution Studies 3Surgical Care Affiliates and UCSD Medical Center to Partner in Surgical Center 8806 1Surgical Care Affiliates and UCSD Medical Center to Partner in Surgical Center 8806 2Fewer Children Outgrowing Allergies to Milk Eggs 8804 1Fewer Children Outgrowing Allergies to Milk Eggs 8804 2Brief intervention helps emergency patients reduce drinking 8802 1Brief intervention helps emergency patients reduce drinking 8802 2Brief intervention helps emergency patients reduce drinking 8802 3U S Census Bureau Daily Feature for December 26 8800 1
...LAMEDA, Calif.--(BUSINESS WIRE)--Jun 21, 2007 - Ad...cessfully produced a human,embryonic stem cell (hE...n Worcester, Massachusetts. This development was a...nd Scientific Development of,Advanced Cell Technol...f the International Society for Stem Cell Research...
...IAMI--(BUSINESS WIRE)--Jun 21, 2007 - Answerthink,...ormed a strategic alliance with,LORENZ Life Scienc...in North America. Answerthink and LORENZ Life Scie...ting best practice submissions,management solution...on SAP technology., Answerthink,s pre-configured E...
Other Medicine Technology:Advanced Cell Technology Develops First Human Embryonic Stem Cell,Line without Destroying an Embryo 2Advanced Cell Technology Develops First Human Embryonic Stem Cell,Line without Destroying an Embryo 3Answerthink and LORENZ Life Sciences Group Announce Strategic,Alliance for the SAP Life Science Industry 2Answerthink and LORENZ Life Sciences Group Announce Strategic,Alliance for the SAP Life Science Industry 3
...is a national reference laboratory and a worldwide...lopment. ARUP offers an extensive test menu of hig...nd anatomic pathology. Owned by the University of ... half of the nation's university teaching hospital...
...is a national reference laboratory and a worldwide...lopment. ARUP offers an extensive test menu of hig...nd anatomic pathology. Owned by the University of ... half of the nation's university teaching hospital...
...is a national reference laboratory and a worldwide...lopment. ARUP offers an extensive test menu of hig...nd anatomic pathology. Owned by the University of ... half of the nation's university teaching hospital...
...is a national reference laboratory and a worldwide...lopment. ARUP offers an extensive test menu of hig...nd anatomic pathology. Owned by the University of ... half of the nation's university teaching hospital...
Medicine Products: